Girin Pascal E R 4
4 · ClearPoint Neuro, Inc. · Filed Apr 2, 2026
Research Summary
AI-generated summary of this filing
ClearPoint Neuro (CLPT) Director Pascal Girin Receives 755-Share Award
What Happened
Pascal E.R. Girin, a non‑employee director of ClearPoint Neuro, received a grant/award of 755 shares of CLPT common stock on April 1, 2026. The shares were issued at $9.10 per share (the closing price on March 31, 2026), for a total value of $6,871. The transaction is reported on a Form 4 as an acquisition/award (code A).
Key Details
- Transaction date: April 1, 2026; filing date: April 2, 2026 (filed within one business day; timely).
- Price per share: $9.10; total value: $6,871.
- Shares issued: 755 shares.
- Shares owned after transaction: Not disclosed in this filing.
- Footnote: Shares were issued pursuant to the issuer’s Sixth Amended and Restated 2013 Incentive Compensation Plan in payment of fees owed under the issuer’s Non‑Employee Director Compensation Plan; issued at the March 31, 2026 closing price.
Context
This was a compensatory grant issued in lieu of director fees, a routine form of non‑employee director compensation. Such awards are standard and do not, by themselves, indicate the insider’s market view.
Insider Transaction Report
Form 4
Girin Pascal E R
Director
Transactions
- Award
Common Stock
[F1]2026-04-01$9.10/sh+755$6,871→ 98,206 total
Footnotes (1)
- [F1]These shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at March 31, 2026.
Signature
/s/ Danilo D'Alessandro, by Power of Attorney for Pascal E. R. Girin|2026-04-02